About Carmel Pharma
Carmel Pharma is a company based in Columbus (United States) founded in 1994 was acquired by Becton Dickinson in July 2011. Carmel Pharma has raised $2.56 million across 2 funding rounds from investors including BD and 3i Group. Carmel Pharma operates in a competitive market with competitors including ICU Medical, Equashield, Corvida Medical and Simplivia, among others.
- Headquarter Columbus, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Carmel Pharma Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.56 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
BD
& 1 more
-
Employee Count
Not available
-
Acquired by
Becton Dickinson
(Jul 27, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Carmel Pharma
Carmel Pharma has successfully raised a total of $2.56M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Carmel Pharma
Carmel Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BD and 3i Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on mid-market businesses
|
Locked | Locked | Locked | |
|
BD is recognized for providing innovative medical technology solutions.
|
Locked | Locked | Locked |
Investor details for Carmel Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Carmel Pharma
Investment portfolio details for Carmel Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Carmel Pharma
Detailed financials for Carmel Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Carmel Pharma Comparisons
Peer comparison for Carmel Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Carmel Pharma
Carmel Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ICU Medical, Equashield, Corvida Medical and Simplivia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug and Infusion delivery devices
|
|
| Locked | Locked | Locked |
Closed-system transfer devices for hazardous drug handling are developed.
|
|
| Locked | Locked | Locked |
Closed system transfer device for safe administration of hazardous drugs
|
|
| Locked | Locked | Locked |
Manufactures closed system transfer devices to protect healthcare workers from drug exposure.
|
Detailed competitors of Carmel Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Carmel Pharma
Complete news archive for Carmel Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Carmel Pharma
Carmel Pharma was founded in 1994 and raised its 1st funding round 5 years after it was founded.
Carmel Pharma is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Carmel Pharma is a funded company, having raised a total of $2.56M across 2 funding rounds to date.
Founded in 1994 and based in Columbus, United States, Carmel Pharma operates in the medical device sector, focusing on the PhaSeal System, an FDA-approved closed-system transfer device. This system is utilized by healthcare providers in hospitals for managing hazardous drugs, with implementations across cancer centers, oncology practices, and specialty pharmacies in the United States, Europe, and Asia. Acquisition by Becton-Dickinson occurred in 2011.
Carmel Pharma's top competitors include Equashield, ICU Medical and Corvida Medical.